Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda

Journal of Infectious Diseases

Volumn 204, Issue 7, 2011, Pages 1120-1124

  Baliraine, Frederick N ^a   Rosenthal, Philip J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; PYRIMETHAMINE PLUS SULFADOXINE;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; GENE; HUMAN; IN VITRO STUDY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; UGANDA;

ALLELES; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PYRIMETHAMINE; SULFADOXINE; TIME FACTORS; UGANDA;

EID: 80052402545     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir486     Document Type: Article

References (15)

1. Stepniewska K., White N.J. Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents Chemother 2008; 52:1589-1596 (Pubitemid 351614647)
2. Mwesigwa J., Parikh S., McGee B., et al. Pharmacokinetics of artemetherlumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrob Agents Chemother 2010; 54:52-59
3. Dokomajilar C., Nsobya S.L., Greenhouse B., Rosenthal P.J. Dorsey G. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother 2006; 50:1893-1895
4. Happi C.T., Gbotosho G.O., Folarin O.A., et al. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother 2009; 53:888-895
5. Humphreys G.S., Merinopoulos I., Ahmed J., et al. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother 2007; 51:991-997 (Pubitemid 46355285)
6. Valderramos S.G., Fidock D.A. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol Sci 2006; 27:594-601. (Pubitemid 44572395)
7. Duraisingh M.T., Jones P., Sambou I., Von Seidlein L., Pinder M.Warhurst D.C. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 2000; 108:13-23. (Pubitemid 30236312)
8. Mwai L., Kiara S.M., Abdirahman A., et al. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother 2009; 53:5069-5073
9. Reed M.B., Saliba K.J., Caruana S.R., Kirk K. Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000; 403:906-909 (Pubitemid 30130994)
10. Duraisingh M.T., Roper C., Walliker D. Warhurst D.C. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol 2000; 36:955-961 (Pubitemid 30326539)
11. Dorsey G., Staedke S., Clark T.D., et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: A randomized trial. JAMA 2007; 297:2210-2219
12. Clark T.D., Njama-Meya D., Nzarubara B., et al. Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children. PLoS One 2010; 5:e11759.
13. Dorsey G., Kamya M.R., Singh A. Rosenthal P.J. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis 2001; 183:1417-1420 (Pubitemid 32337128)
14. Huijben S., Nelson W.A., Wargo A.R., Sim D.G., Drew D.R. Read A.F. Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites. Evolution 2010; 64:2952-2968
15. Nsobya S.L., KiggunduM., Nanyunja S., JolobaM., Greenhouse B. Rosenthal P.J. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob Agents Chemother 2010; 54:1200-1206